Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience

Abstract Background Real‐world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited. Objective To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance,...

Full description

Bibliographic Details
Published in:Journal of Arrhythmia
Main Authors: Min Choon Tan, Jian Liang Tan, Wei Jun Lee, Komandoor Srivathsan, Dan Sorajja, Hicham El Masry, Luis R. Scott, Justin Z. Lee
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2023
Subjects:
Online Access:https://doi.org/10.1002/joa3.12898
https://doaj.org/article/9ab3c6d6c3d14f348a694c99267844c7
id ftdoajarticles:oai:doaj.org/article:9ab3c6d6c3d14f348a694c99267844c7
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:9ab3c6d6c3d14f348a694c99267844c7 2023-11-05T03:39:06+01:00 Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience Min Choon Tan Jian Liang Tan Wei Jun Lee Komandoor Srivathsan Dan Sorajja Hicham El Masry Luis R. Scott Justin Z. Lee 2023-10-01T00:00:00Z https://doi.org/10.1002/joa3.12898 https://doaj.org/article/9ab3c6d6c3d14f348a694c99267844c7 EN eng Wiley https://doi.org/10.1002/joa3.12898 https://doaj.org/toc/1880-4276 https://doaj.org/toc/1883-2148 1883-2148 1880-4276 doi:10.1002/joa3.12898 https://doaj.org/article/9ab3c6d6c3d14f348a694c99267844c7 Journal of Arrhythmia, Vol 39, Iss 5, Pp 784-789 (2023) adverse events atrial fibrillation cryoballoon ablation outcome assessment pulmonary vein isolation Diseases of the circulatory (Cardiovascular) system RC666-701 article 2023 ftdoajarticles https://doi.org/10.1002/joa3.12898 2023-10-08T00:36:46Z Abstract Background Real‐world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited. Objective To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance, and Arctic Front Advance Pro) reported in the Food and Drug Administration's (FDA) Manufacturers and User Defined Experience (MAUDE) database. Methods We reviewed all the adverse events reported to the FDA MAUDE database over a 10.7‐year study period from January 01, 2011 to September 31, 2021. All events were independently reviewed by two physicians. Results During the study period, a total of 320 procedural‐related adverse events reported in the MAUDE database were identified. The most common adverse event was transient or persistent phrenic nerve palsy (PNP), accounting for 48% of all events. This was followed by cardiac perforation (15%), pulmonary vein stenosis (8%), transient ischemic attack or stroke (6%), vascular injury (4%), transient or persistent ST‐elevation myocardial infarction (3%), hemoptysis (2%), pericarditis (2%), and esophageal ulcer or fistula (1%). There were six reported intra‐procedural death events as a result of cardiac perforation. Conclusion The two most common procedural adverse events associated with cryoballoon ablation were PNP and cardiac perforation. All cases of procedural mortality were due to cardiac perforation. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Journal of Arrhythmia 39 5 784 789
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic adverse events
atrial fibrillation
cryoballoon ablation
outcome assessment
pulmonary vein isolation
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle adverse events
atrial fibrillation
cryoballoon ablation
outcome assessment
pulmonary vein isolation
Diseases of the circulatory (Cardiovascular) system
RC666-701
Min Choon Tan
Jian Liang Tan
Wei Jun Lee
Komandoor Srivathsan
Dan Sorajja
Hicham El Masry
Luis R. Scott
Justin Z. Lee
Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
topic_facet adverse events
atrial fibrillation
cryoballoon ablation
outcome assessment
pulmonary vein isolation
Diseases of the circulatory (Cardiovascular) system
RC666-701
description Abstract Background Real‐world clinical data on the adverse events related to the use of cryoballoon catheter for pulmonary vein isolation remains limited. Objective To report and describe the adverse events related to the use of Artic Front cryoballoon catheters (Arctic Front, Arctic Front Advance, and Arctic Front Advance Pro) reported in the Food and Drug Administration's (FDA) Manufacturers and User Defined Experience (MAUDE) database. Methods We reviewed all the adverse events reported to the FDA MAUDE database over a 10.7‐year study period from January 01, 2011 to September 31, 2021. All events were independently reviewed by two physicians. Results During the study period, a total of 320 procedural‐related adverse events reported in the MAUDE database were identified. The most common adverse event was transient or persistent phrenic nerve palsy (PNP), accounting for 48% of all events. This was followed by cardiac perforation (15%), pulmonary vein stenosis (8%), transient ischemic attack or stroke (6%), vascular injury (4%), transient or persistent ST‐elevation myocardial infarction (3%), hemoptysis (2%), pericarditis (2%), and esophageal ulcer or fistula (1%). There were six reported intra‐procedural death events as a result of cardiac perforation. Conclusion The two most common procedural adverse events associated with cryoballoon ablation were PNP and cardiac perforation. All cases of procedural mortality were due to cardiac perforation.
format Article in Journal/Newspaper
author Min Choon Tan
Jian Liang Tan
Wei Jun Lee
Komandoor Srivathsan
Dan Sorajja
Hicham El Masry
Luis R. Scott
Justin Z. Lee
author_facet Min Choon Tan
Jian Liang Tan
Wei Jun Lee
Komandoor Srivathsan
Dan Sorajja
Hicham El Masry
Luis R. Scott
Justin Z. Lee
author_sort Min Choon Tan
title Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_short Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_full Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_fullStr Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_full_unstemmed Adverse events in cryoballoon ablation for pulmonary vein isolation: Insight from the Food and Drug Administration Manufacturer and User Facility Device Experience
title_sort adverse events in cryoballoon ablation for pulmonary vein isolation: insight from the food and drug administration manufacturer and user facility device experience
publisher Wiley
publishDate 2023
url https://doi.org/10.1002/joa3.12898
https://doaj.org/article/9ab3c6d6c3d14f348a694c99267844c7
genre Arctic
genre_facet Arctic
op_source Journal of Arrhythmia, Vol 39, Iss 5, Pp 784-789 (2023)
op_relation https://doi.org/10.1002/joa3.12898
https://doaj.org/toc/1880-4276
https://doaj.org/toc/1883-2148
1883-2148
1880-4276
doi:10.1002/joa3.12898
https://doaj.org/article/9ab3c6d6c3d14f348a694c99267844c7
op_doi https://doi.org/10.1002/joa3.12898
container_title Journal of Arrhythmia
container_volume 39
container_issue 5
container_start_page 784
op_container_end_page 789
_version_ 1781694899449495552